Tetrahydrofuran → 1-(2,3-Dihydroxypropyl)-N-(6-ethyl-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)cyclopropane-1-sulfonamide
Reaction equation
[CH2:1]([C:4]1([S:7]([NH:10][C:11]2[C:16](C)=[CH:15][C:14]([F:18])=[C:13]([F:19])[C:12]=2[NH:20][C:21]2[CH:26]=[CH:25][C:24]([I:27])=[CH:23][C:22]=2[F:28])(=[O:9])=[O:8])[CH2:6][CH2:5]1)C=C.C[N+]1([O-])CCO[CH2:32][CH2:31]1.CCO[C:40]([CH3:42])=[O:41].C1C[O:46]CC1>O.[Os](=O)(=O)(=O)=O>[OH:46][CH:42]([CH2:40][OH:41])[CH2:1][C:4]1([S:7]([NH:10][C:11]2[C:16]([CH2:31][CH3:32])=[CH:15][C:14]([F:18])=[C:13]([F:19])[C:12]=2[NH:20][C:21]2[CH:26]=[CH:25][C:24]([I:27])=[CH:23][C:22]=2[F:28])(=[O:9])=[O:8])[CH2:5][CH2:6]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
1-Allyl-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methylphenyl)cyclopropane-1-sulfonamide (70 mg, 0.13 mmol) and 4-methylmorpholine N-oxide (15 mg, 0.13 mmol) was dissolved in THF (2 mL). Osmium tetroxide was added at room temperature (0.013 mmol) 0.075 mL, 4% in H2O) and the reaction mixture was stirred at room temperature for 16 hours. EtOAc was added, the organic phase was washed with water, dried (MgSO4) and concentrated under reduced pressure. The residue was purified over silica gel chromatography (eluants: EtOAc/MeOH) to obtain the titled product. 1H NMR (300 MHz, CDCl3): δ 7.38 (dd, J=2.1 & 10.8 Hz, 1H), 7.27 (m, 2H), 7.12 (br s, 1H), 6.91 (dd, J=8.1 & 10.8 Hz, 1H), 6.69 (br s, 1H), 6.36 (dt, J=4.8, 8.7 & 13.5 Hz, 1H), 4.00 (m, 1H), 3.62 (dd, J=3.6 & 10.5 Hz, 1H), 3.47 (br m, 2H), 2.81 (q, 2H), 2.40 (dd, J=10.2 & 15.9 Hz, 1H), 1.73 (br m, 2H), 1.58 (m, 1H), 1.43 (m, 1H), 0.94 (m, 2H).
Workup
- washthe organic phase was washed with water
- dry with materialdried (MgSO4)
- concentrationconcentrated under reduced pressure
- customThe residue was purified over silica gel chromatography (eluants: EtOAc/MeOH)
Sources & evidence
- ORD record
- ord-b632eca819d34dfa9f8878f452584f7d
- Source dataset
- uspto-grants-2010_07
- Patent number
- US07759518B2
Reaction notes
Loading…